https://www.vortexcapital.io https://www.vortexcapital.io/transaction https://www.vortexcapital.io/global-investor-presence https://www.vortexcapital.io/privacy-policy https://www.vortexcapital.io/corporate-presentation https://www.vortexcapital.io/our-team https://www.vortexcapital.io/terms-of-service https://www.vortexcapital.io/latest-news https://www.vortexcapital.io/insights https://www.vortexcapital.io/insights/biotech-patent-cliff-2026 https://www.vortexcapital.io/insights/clinical-trials-china-cost-curves https://www.vortexcapital.io/insights/fabian-kis-and-dimitri-dieterle-on-investor-shifts-and-path-to-allocation https://www.vortexcapital.io/insights/liquidity-stress-capital-formation-venture https://www.vortexcapital.io/insights/macroeconomic-constraints-and-lp-liquidity-shape-venture-deployment-in-2025 https://www.vortexcapital.io/insights/middle-eastern-sovereign-capital-projects https://www.vortexcapital.io/insights/oil-gas-liquidity-control https://www.vortexcapital.io/insights/private-markets-new-public-markets https://www.vortexcapital.io/insights/venture-selectivity-and-capital-discipline-shape-biotech-financings-in-2025